The Flowr Corporation Announces International Commercialization of Its Flagship Strains – BC Black Cherry and BC Strawnana

Published: January 17, 2022

The Flowr Corporation Announces International Commercialization of Its Flagship Strains – BC Black Cherry and BC Strawnana

The Flowr Corporation announced that it has completed its first shipment from Canada to Israel, as part of the previously announced international supply agreement with Focus Medical Herbs Ltd., a company which IM Cannabis Corp. has an exclusive commercial agreement with in Israel.

The first shipment consisted of premium cannabis across two strains for a total of $825,000. The shipment represents the Company’s debut into the Israeli market and the first significant international export. Additional exports of premium cannabis to Israel are expected in 2022 pursuant to the Supply Agreement.

“We are extremely pleased to have completed our first shipment to Israel as part of our partnership with IMC and Focus Medical,” commented Darryl Brooker, Chief Executive Officer of Flowr. “As the Israeli medical cannabis industry continues to grow, we expect the market to be an important destination for us to grow our brand and distribution reach internationally. As a result, we view this first shipment, and this partnership as an important next step to becoming a significant international producer of cannabis with a globally recognized brand.”

The first shipment of cannabis was from the Company’s K1 facility located in Kelowna, British Columbia, which is a world-class facility capable of producing award winning high-THC strains, with a high level of consistency. The Company expects a second shipment to be available in the Israeli market in the first half of 2022. The partnership with Focus Medical is for a period of three years, subject to certain early termination provisions and applicable regulatory requirements including the receipt of import and export permits.

The Company is also pleased to announce today that in Portugal, its wholly-owned subsidiary, Holigen Holdings Limited (“Holigen”), expects to harvest at least 300 kilograms of indoor grown medical cannabis in the first quarter of 2022. Holigen is in the final stages of cultivating BC Black Cherry and BC Strawnana strains and expects to commence harvesting at its purpose-built indoor facility in Sintra, Portugal by the end of January 2022. Initial in-process testing for its medical cannabis are indicating THC content levels above 29%.

“Our strategy in Portugal is appearing to pay dividends. We have worked very hard to improve the operational expertise at our indoor facility in Sintra and we are now seeing the results. The E.U. market is starved for premium medical cannabis and our team in Portugal, led by Tom Flow, is on the cusp of achieving a significant operational milestone for the Company,” commented Darryl Brooker. “We are very much looking forward to the near-term results in Portugal and see the E.U. as an under-valued and under-appreciated part of our business.”

About The Flowr Corporation
The Flowr Corporation is a Canadian cannabis company with operations in Canada and the European Union. Its Canadian operating campus, located in Kelowna, BC, includes a purpose-built, GMP-designed indoor cultivation facility; an outdoor and greenhouse cultivation site; and a state-of-the-art R&D facility. From this campus, Flowr produces recreational and medicinal products. Flowr aims to support improving outcomes through responsible cannabis use and, as an established expert in cannabis cultivation, strives to be the brand of choice for consumers and patients seeking the highest-quality craftsmanship and product consistency across a portfolio of differentiated cannabis products. For more information, please visit

About IMC
IM Cannabis is a leading international cannabis company providing premium products to medical patients and adult-use recreational consumers. IM Cannabis is one of the very few companies with operations in Israel, Germany, and Canada, the three largest federally legal markets. The ecosystem created through its international operations leverages the Company’s unique data-driven perspective and product supply chain globally. With its commitment to responsible growth and financial prudence, and the ability to operate within the strictest regulatory environments, the Company has quickly become one of the leading cultivators and distributors of high-quality cannabis globally.

Recent News

View All News Items

Latest Article

How Database Integrations Can Improve Every Step in Your Cannabis Supply Chain Labeling

How Database Integrations Can Improve Every Step in Your Cannabis Supply Chain Labeling

At any step in the cannabis supply chain, your labeling system should allow for full control and traceability, from seed to sale. Implementing lean principles and labeling best practices across the cannabis supply chain can help you streamline your seed-to-sale labeling process and help you gain control.

Click below to read the full blog and learn how to reduce waste, cut costs, and gain efficiency with cannabis labeling:

Read Article